Three Dimensional Breast Tomosynthesis denials in California external review

In the California DMHC record, independent physician reviewers decided 20 published external-review cases involving Three Dimensional Breast Tomosynthesisand overturned the plan’s denial in 95%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
20
2015–2016
Overturned
95%
19 denials reversed

Conditions behind Three Dimensional Breast Tomosynthesis denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Dense Breast Tissue4
100%
Breast Cancer Screening4
100%
Typical time to a decision
21 days
Most land between 20 and 21 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested three-dimensional breast tomosynthesis for evaluation of her medical condition. Findings: Three physician reviewers found that breast tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography (CT) scanning, the logic is that by separating the various layers of breast tissue, one can better detect abnormalities. This has been shown to be most useful in the evaluation of dense breasts.
Experimental/Investigational · 2016 · IMR EI16-21332
Nature of Statutory Criteria/Case Summary: An enrollee requested three-dimensional (3D) breast tomosynthesis for medical evaluation of her medical condition. Findings: Three physician reviewers found that the diagnostic procedure at issue was likely to be more beneficial for evaluation of the patient’s medical condition than available standard modalities. There is support in the medical literature for the 3D breast tomosynthesis performed in this clinical setting. The medical literature reported the effect of integrated 2D and 3D mammography in population breast-cancer screening. The medical literature concluded that “Integrated 2D and 3D mammography improves breast-cancer detection and has the potential to reduce false positive recalls.
Experimental/Investigational · 2015 · IMR EI15-20486

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested three-dimensional (3D) breast tomosynthesis for evaluation of her medical condition. Findings: Two physician reviewers found that review of the submitted documentation and relevant literature fails to support the services at issue in this clinical setting. There is a lack of evidence in the peer-reviewed literature that supports the use of breast tomosynthesis compared to currently available techniques. Although digital breast tomosynthesis is a promising technology its clinical efficacy has yet to be substantiated in the peer-reviewed literature. As such, the services at issue were not likely to be more beneficial than standard modalities.
Experimental/Investigational · 2015 · IMR EI15-21095

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Three Dimensional Breast Tomosynthesis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Three Dimensional Breast Tomosynthesis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9